Tanis D. Godwin
Dunedin, OTA, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Hereditary diffuse gastric cancer: the evolution of a cancer syndrome.
Journal: Journal of the Royal Society of New Zealand
Published: August 04, 2025
E-cadherin loss in Cd44-positive gastric cells initiates diffuse gastric cancer in a murine model.
Journal: Gut
Published: June 18, 2025
E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib.
Journal: Cancers
Published: January 31, 2022
E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC Inhibitors.
Journal: Cancers
Published: December 04, 2021
Modelling hereditary diffuse gastric cancer initiation using transgenic mouse-derived gastric organoids and single-cell sequencing.
Journal: The Journal of pathology
Published: December 30, 2020
Hereditary diffuse gastric cancer: updated clinical practice guidelines.
Journal: The Lancet. Oncology
Published: February 12, 2020
Allosteric AKT Inhibitors Target Synthetic Lethal Vulnerabilities in E-Cadherin-Deficient Cells.
Journal: Cancers
Published: July 29, 2019
E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: June 11, 2018
E-cadherin signal sequence disruption: a novel mechanism underlying hereditary cancer.
Journal: Molecular cancer
Published: May 18, 2018
Synthetic Lethal Screens Identify Vulnerabilities in GPCR Signaling and Cytoskeletal Organization in E-Cadherin-Deficient Cells.
Journal: Molecular cancer therapeutics
Published: December 26, 2014
E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition.
Journal: BMC cancer
Published: April 04, 2014
Last Updated: 09/26/2026